Research location
Nantong
Jiangsu, China
Advertisement
Research activity in Nantong
Jiangsu, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 103 trials and 109 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Nantong
103 linked trials · page 1 of 3Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid ArthritisNCT07796516 · 2026-09-01 · 1 site observation
RECRUITING
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic DiseaseNCT07492641 · 2026-05-22 · 1 site observation
RECRUITING
QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast CancerNCT07342283 · 2026-02-25 · 1 site observation
RECRUITING
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsNCT07185997 · 2025-12-17 · 1 site observation
RECRUITING
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.NCT07028853 · 2025-09-28 · 1 site observation
RECRUITING
Screening of Predictive Biomarkers for Cardiorenal SyndromeNCT07139626 · 2025-09-15 · 1 site observation
RECRUITING
Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF PatientsNCT07167368 · 2025-09-15 · 1 site observation
RECRUITING
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)NCT07154706 · 2025-08-21 · 1 site observation
RECRUITING
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke PopulationsNCT06935513 · 2025-04-20 · 1 site observation
RECRUITING
Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate CancerNCT06834321 · 2025-03-19 · 1 site observation
RECRUITING
Study on the Molecular Mechanism of Berberine to Improve Type 2 Diabetes Mellitus Complicated With DepressionNCT06979440 · 2024-11-09 · 1 site observation
RECRUITING
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.NCT06629779 · 2024-10-22 · 1 site observation
RECRUITING
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy FailureNCT06300177 · 2024-03-28 · 1 site observation
RECRUITING
Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III)NCT06283758 · 2024-03-01 · 1 site observation
RECRUITING
A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPCNCT06241846 · 2024-02-22 · 1 site observation
RECRUITING
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)NCT06136650 · 2023-12-18 · 1 site observation
RECRUITING
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's DiseaseNCT05908695 · 2023-08-31 · 1 site observation
RECRUITING
Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)NCT05909332 · 2023-06-20 · 1 site observation
RECRUITING
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)NCT05891093 · 2023-06-01 · 1 site observation
RECRUITING
To Assess the Safety and Efficacy of the Atrial Shunt Implant System in the Treatment of Patients With Chronic Left Heart FailureNCT05486000 · 2022-08-01 · 1 site observation
RECRUITING
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT04928846 · 2022-03-25 · 1 site observation
RECRUITING
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7NCT04613596 · 2020-12-02 · 2 site observations
RECRUITING
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cmNCT04937283 · 2019-10-01 · 2 site observations
RECRUITING
The Chinese Familial Alzheimer's NetworkNCT03657732 · 2005-01-10 · 1 site observation
RECRUITING
China Cognition and Aging StudyNCT03653156 · 2000-01-01 · 1 site observation
RECRUITING
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or ObesityNCT07792954 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney DiseaseNCT07667517 · 2026-07-01 · 1 site observation
NOT_YET_RECRUITING
Left Ventricular Myocardial Work for Predicting Response to CRTNCT07319065 · 2026-01-01 · 2 site observations
NOT_YET_RECRUITING
A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid ArthritisNCT07100938 · 2025-08-21 · 1 site observation
TERMINATED
CT-Free Electromagnetic Navigation Percutaneous Localization for Pulmonary Nodules Undergoing Sublobar ResectionNCT07743775 · 2025-06-24 · 3 site observations
COMPLETED
The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.NCT07077811 · 2025-06-01 · 1 site observation
ENROLLING_BY_INVITATION
Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.NCT06885840 · 2025-03-31 · 1 site observation
NOT_YET_RECRUITING
Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast CancerNCT06702618 · 2025-02-20 · 1 site observation
ACTIVE_NOT_RECRUITING
The Role of Early Nursing Intervention in the High-risk Population of Gestational DiabetesNCT06997835 · 2025-01-01 · 1 site observation
ACTIVE_NOT_RECRUITING
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).NCT06606509 · 2024-11-07 · 1 site observation
NOT_YET_RECRUITING
Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLCNCT06709274 · 2024-11-01 · 1 site observation
NOT_YET_RECRUITING
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).NCT06551324 · 2024-10-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive DisorderNCT07253207 · 2024-10-17 · 1 site observation
COMPLETED
Good-first: B/F/TAF As First-line ARTNCT06619288 · 2024-07-01 · 1 site observation
UNKNOWN
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBCNCT06419621 · 2024-06-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Clinical Study of Lung Protective Ventilation Strategies and Tumor MicroenvironmentNCT06230965 · 2024-01-25 · 1 site observation
COMPLETED
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver DiseaseNCT06501326 · 2023-11-01 · 1 site observation
UNKNOWN
Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral MetastasisNCT05860907 · 2023-10-01 · 1 site observation
NOT_YET_RECRUITING
Effectiveness of Health Literacy Enhancement Program Among Older Persons With Physical MultimorbidityNCT06313138 · 2023-07-15 · 1 site observation
COMPLETED
A Multicenter Clinical Study of rTMS for Parkinson's DiseaseNCT06009471 · 2023-07-01 · 1 site observation
UNKNOWN
Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.NCT05922345 · 2023-06-08 · 1 site observation
UNKNOWN
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 DiabetesNCT05872620 · 2023-06-05 · 1 site observation
COMPLETED
A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCCNCT05212922 · 2023-06-01 · 1 site observation
WITHDRAWN
Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)NCT05778097 · 2023-04-01 · 1 site observation
NOT_YET_RECRUITING
Effect of HMP on Diabetic Microangiopaemia in T2DMNCT05095922 · 2023-03-28 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.